Brief:

H/Advisors Cicero supported a global pharmaceutical company with a public affairs and policy landscaping campaign in the rare disease and orphan drug landscape. The project spanned 13 countries across Europe, North and South America, Asia-Pacific, the UK and Turkey.​ 

Strategy and execution​

H/Advisors Cicero produced a comprehensive report based on desktop research and interaction with the broader H/Advisors network in the US, Brazil, China, Japan, EU and Germany. H/Advisors Cicero also summarised our findings into a comprehensive PowerPoint deck which outlined the political and policy landscape and gave strategic advice on future engagement.​

Result:

Our policy and public affairs engagement has assisted in the development of the company’s global rare disease advocacy positioning.